1. Han, C. & Pae, C.U. (2013) Do we need to consider ethno-cultural variation in the use of atypical antipsychotics for Asian patients with major depressive disorder? CNS Drugs, 27, S47-51.
2. Hecht, D. (2010) Depression and the hyperactive right-hemisphere. Neurosci. Res., 68, 77-87.
3. Hein, S., Bonsignore, M., Barkow, K., Jessen, F., Ptok, U. & Heun, R. (2003) Lifetime depressive and somatic symptoms as preclinical markers of late-onset depression. Eur. Arch. Psychiatry Clin. Neurosci., 253, 16-21.
4. Iniesta, R., Malki, K., Maier, W., Rietschel, M., Mors, O., Hauser, J., Henigsberg, N., Dernovsek, M.Z., Souery, D., Stahl, D., Dobson, R., Aichison, K.J., Farmer, A., Lewis, C.M., McGuffin, P. & Uher, R. (2016) Combing clinical variables to optimize prediction of antidepressant treatment outcomes. J. Psychiatr. Res., 78, 94-102.
5. Joensuu, M., Ahola, P., Knekt, P., Lindfors, O., Saarinen, P., Tolmulen, T., Valkonen-Korhonen, M., Vanninen, R., Jaaskelainen, T., Virtala, E., Kuikka, J., Tihonen, J. & Lehtonen, J. (2016) Baseline symptom severity predicts serotonin transporter change during psychotherapy in patients with major depression. Psychiatry Clin. Neurosci., 70, 34-41.